Krka Awarded Damages in Suit Against AstraZeneca
Novo mesto, 7 April - Slovenian drug maker Krka said on Monday it had been awarded about EUR 21m in damages and court costs in a lawsuit concerning the sale of the drug Esomeprazole in the UK.
The rest of this news item is available to subscribers.
The news item consists of 241 characters (without spaces) or 51 words words.
Buy the news item. Price: 2 tokens; on account: 0 tokens.